Charles River Laboratories | CRL - Assets

Stock Price
200.99
Daily Change
-0.42 -0.21%
Monthly
-3.52%
Yearly
21.17%
Q1 Forecast
204.00

Charles River Laboratories reported $7.51B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Agilent USD 12.73B 501M Sep/2025
Align Technology USD 6.23B 14.46M Sep/2025
Bio-Rad Laboratories USD 9.7B 517.7M Sep/2025
Bruker USD 6.43B 95.1M Sep/2025
Cardinal Health USD 55.23B 2.11B Sep/2025
Charles River Laboratories USD 7.51B 46.73M Sep/2025
Cigna USD 157.92B 6.27B Sep/2025
CVS Health USD 255.33B 3.02B Sep/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.65B 416M Sep/2025
Elevance Health USD 121.49B 1.26B Dec/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Hologic USD 9.18B 165.8M Dec/2025
Humana USD 49.72B 638M Sep/2025
Illumina USD 6.18B 90M Sep/2025
Incyte USD 6.33B 509M Sep/2025
IQVIA Holdings USD 28.73B 95M Sep/2025
Laboratory Of America USD 18.26B 201.7M Sep/2025
Lonza CHF 19.73B 1.85B Dec/2024
McKesson USD 84.16B 2.85B Sep/2025
Merck EUR 50.93B 3.58B Sep/2025
Mettler Toledo International USD 3.52B 121M Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Quest Diagnostics USD 16.2B 228M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
United Therapeutics USD 7.35B 556.9M Sep/2025
UnitedHealth USD 309.58B 5.69B Dec/2025
Waters USD 4.86B 144.49M Sep/2025
West Pharmaceutical Services USD 4.11B 153M Sep/2025